C07C 49/507
Polycyclic
Official title: polycyclic
C07C49/507 (Polycyclic) appears on 68 US grants and 27 published applications in this corpus.
Search patents in C07C- Granted patents
- 68
- Published applications
- 27
- Assignees
- 36
- Inventors
- 111
- Latest grant
- 2 Jan 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 4 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 5 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 2 |
| 2004 | 2 | 1 |
| 2005 | 0 | 1 |
| 2006 | 1 | 0 |
| 2007 | 1 | 2 |
| 2008 | 1 | 3 |
| 2009 | 1 | 1 |
| 2010 | 1 | 1 |
| 2011 | 1 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 3 |
| 2015 | 2 | 1 |
| 2016 | 1 | 2 |
| 2017 | 1 | 1 |
| 2018 | 1 | 2 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 2 |
| 2022 | 1 | 1 |
| 2023 | 1 | 1 |
| 2024 | 1 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Compound for modulating DDAH and ADMA levels, as well as methods of using thereof to treat disease2 Jan 2024US 11,858,889 B2The Trustees of Indiana University
- Illudin analogs, uses thereof, and methods for synthesizing the same29 Aug 2023US 11,739,043 B2Lantern Pharma Inc.
- Compound for modulating DDAH and ADMA levels, as well as methods of using thereof to treat disease8 Mar 2022US 11,267,780 B2The Trustees of Indiana University
- Process for the preparation of 17β-hydroxy-des-A-androst-9,10-en-5-one29 Jan 2019US 10,189,765 B2Industriale Chimica S.R.L.
- Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors25 Dec 2018US 10,160,738 B2Washington University
- Illudin analogs, uses thereof, and methods for synthesizing the same14 Dec 2023US 2023/0399285 A1Lantern Pharma Inc.
- Compound for modulating ddah and adma levels, as well as methods of using thereof to treat disease12 May 2022US 2022/0144795 A1The Trustees of Indiana University
- Illudin analogs, uses thereof, and methods for synthesizing the same1 Jul 2021US 2021/0198191 A1Lantern Pharma Inc.
- Compound for modulating ddah and adma levels, as well as methods of using thereof to treat disease14 Jan 2021US 2021/0009498 A1The Trustees of Indiana Univerity
- New Pleuromutilin Antibiotic Compounds, Compositions and Methods of Use and Synthesis21 Nov 2019US 2019/0352262 A1Yale University
Most cited
By later US patents
- Ketone compounds and compositions for cholesterol management and related uses56US 6,699,910 B2Esperion Therapeutics, Inc. · 2004
- Ketone compounds and compositions for cholesterol management and related uses30US 7,304,093 B2Esperion Therapeutics, Inc. · 2007
- Synthesis of 4-hydroxy-2-adamantanes and related compounds27US 5,430,193 AMobil Oil Corporation · 1995
- Vitamin D compounds and method of preparing these compounds27US 5,449,668 ADuphar International Research B.V. · 1995
- Derivatives of long chain fatty alcohols, their uses, particularly as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing them21US 5,243,094 AMedafor, Incorporated · 1993